Juanyi Shi

983 total citations
29 papers, 626 citations indexed

About

Juanyi Shi is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Juanyi Shi has authored 29 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Juanyi Shi's work include Circular RNAs in diseases (11 papers), MicroRNA in disease regulation (10 papers) and Cancer-related molecular mechanisms research (8 papers). Juanyi Shi is often cited by papers focused on Circular RNAs in diseases (11 papers), MicroRNA in disease regulation (10 papers) and Cancer-related molecular mechanisms research (8 papers). Juanyi Shi collaborates with scholars based in China and Canada. Juanyi Shi's co-authors include Tianxin Lin, Luping Chen, Yinjie Su, Junming Bi, Wei Dong, Ning Jiang, Jian Huang, Jian Huang, Meihua Yang and Hongwei Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Molecular Cancer and BMC Cancer.

In The Last Decade

Juanyi Shi

28 papers receiving 625 citations

Peers

Juanyi Shi
Manmei Long China
Ailin Qu China
Hanhao Zheng China
Sandra Santasusagna Spain
Zeyin Rong China
Shouguo Sun China
Dali Yan China
Bai‐Quan Qiu China
Tian Liang China
Baoming Mi China
Manmei Long China
Juanyi Shi
Citations per year, relative to Juanyi Shi Juanyi Shi (= 1×) peers Manmei Long

Countries citing papers authored by Juanyi Shi

Since Specialization
Citations

This map shows the geographic impact of Juanyi Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juanyi Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juanyi Shi more than expected).

Fields of papers citing papers by Juanyi Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juanyi Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juanyi Shi. The network helps show where Juanyi Shi may publish in the future.

Co-authorship network of co-authors of Juanyi Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Juanyi Shi. A scholar is included among the top collaborators of Juanyi Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juanyi Shi. Juanyi Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hu, Jintao, Juanyi Shi, Shizhong Xu, et al.. (2025). A novel polypeptide encoded by circSPIRE1 promotes prostate cancer proliferation and migration by restraining the ubiquitin-dependent degradation of LRP5. Journal of Experimental & Clinical Cancer Research. 44(1). 218–218. 1 indexed citations
3.
4.
Cheng, Yi‐Bing, et al.. (2025). Prospects of engineered exosomes in clinical applications: a review. Drug Development and Industrial Pharmacy. 51(11). 1400–1416. 1 indexed citations
5.
Luo, Jiawen, Juanyi Shi, Jintao Hu, et al.. (2024). The predictive significance of chromobox family members in prostate cancer in humans. Cellular Oncology. 47(4). 1315–1331. 3 indexed citations
6.
Liu, Cheng, Juanyi Shi, Ze Gao, et al.. (2023). HMMR promotes prostate cancer proliferation and metastasis via AURKA/mTORC2/E2F1 positive feedback loop. Cell Death Discovery. 9(1). 48–48. 15 indexed citations
7.
Li, Zhuohang, Xin Huang, Hao Yu, et al.. (2023). Single-cell analysis extracted CAFs-related genes to established online app to predict clinical outcome and radiotherapy prognosis of prostate cancer. Clinical & Translational Oncology. 26(5). 1240–1255. 7 indexed citations
8.
Ye, Huilin, Liqiang Liu, Juanyi Shi, et al.. (2023). Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer. Journal of Translational Medicine. 21(1). 717–717. 12 indexed citations
9.
Wen, Kai, Yang Feng, Lei Hu, et al.. (2023). Analysis of the potential association between ferroptosis and immune in hepatocellular carcinoma and their relationship with prognosis. Frontiers in Oncology. 12. 2 indexed citations
10.
Liu, Qinghua, Juanyi Shi, Zhenyu Zhou, et al.. (2022). Prognostic nomogram for predicting cancer-specific survival in patients with resected hilar cholangiocarcinoma: a large cohort study. Journal of Gastrointestinal Oncology. 13(2). 833–846. 5 indexed citations
11.
Su, Yinjie, et al.. (2021). Correction to: circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway. Molecular Cancer. 20(1). 1–1. 23 indexed citations
12.
Wu, Zhenyu, Juanyi Shi, Kaiwen Li, et al.. (2021). Clinicopathological significance and prognostic value of cancer-associated fibroblasts in prostate cancer patients. Urologic Oncology Seminars and Original Investigations. 39(7). 433.e17–433.e23. 20 indexed citations
13.
Wen, Kai, Yongcong Yan, Juanyi Shi, et al.. (2021). Construction and Validation of a Combined Ferroptosis and Hypoxia Prognostic Signature for Hepatocellular Carcinoma. Frontiers in Molecular Biosciences. 8. 809672–809672. 14 indexed citations
14.
Shi, Juanyi, Kai Wen, Jianhong Lin, et al.. (2021). Molecular Targets of Ferroptosis in Hepatocellular Carcinoma. SHILAP Revista de lepidopterología. Volume 8. 985–996. 24 indexed citations
15.
Shi, Juanyi, et al.. (2021). A Novel Risk Factor Model Based on Glycolysis-Associated Genes for Predicting the Prognosis of Patients With Prostate Cancer. Frontiers in Oncology. 11. 605810–605810. 13 indexed citations
16.
Su, Yinjie, et al.. (2020). circRIP2 accelerates bladder cancer progression via miR-1305/Tgf-β2/smad3 pathway. Molecular Cancer. 19(1). 23–23. 120 indexed citations
17.
18.
Wu, Zhenyu, et al.. (2020). Autophagy-related long noncoding RNAs can predict prognosis in patients with bladder cancer. Aging. 12(21). 21582–21596. 14 indexed citations
19.
Su, Yinjie, Weiping Yang, Ning Jiang, et al.. (2019). Hypoxia-elevated circELP3 contributes to bladder cancer progression and cisplatin resistance. International Journal of Biological Sciences. 15(2). 441–452. 72 indexed citations
20.
Liu, Hongwei, Junming Bi, Wei Dong, et al.. (2018). Invasion-related circular RNA circFNDC3B inhibits bladder cancer progression through the miR-1178-3p/G3BP2/SRC/FAK axis. Molecular Cancer. 17(1). 161–161. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manmei Long Breakdown of academic impact, for papers by Ailin Qu Breakdown of academic impact, for papers by Hanhao Zheng Breakdown of academic impact, for papers by Sandra Santasusagna Breakdown of academic impact, for papers by Zeyin Rong Breakdown of academic impact, for papers by Shouguo Sun Breakdown of academic impact, for papers by Dali Yan Breakdown of academic impact, for papers by Bai‐Quan Qiu Breakdown of academic impact, for papers by Tian Liang Breakdown of academic impact, for papers by Baoming Mi
Rankless by CCL
2026